HCW Biologics annual operating expenses
2020
2021
2022
2023
2024
2025
HCW Biologics Operating Expenses Growth & History (HCWB)
HCW Biologics's operating expenses was $13.2M for fiscal 2025.
View full HCW Biologics company overviewHCW Biologics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.2M | −$17.2M | −56.69% |
| 2024 | 2024-12-31 | $30.4M | $4.1M | +15.75% |
| 2023 | 2023-12-31 | $26.3M | $8.6M | +48.75% |
| 2022 | 2022-12-31 | $17.7M | $4.3M | +32.15% |
| 2021 | 2021-12-31 | $13.4M | $3.4M | +34.70% |
| 2020 | 2020-12-31 | $9.9M | — | — |
HCW Biologics quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.1M | −$392,985 | −11.34% |
| Q1 2026 | 2026-03-31 | $3.3M | $1.3M | +67.59% |
| Q4 2025 | 2025-12-31 | $4.4M | $1.2M | +38.02% |
| Q3 2025 | 2025-09-30 | $3.3M | −$474,578 | −12.59% |
| Q2 2025 | 2025-06-30 | $3.5M | −$11.9M | −77.37% |
| Q1 2025 | 2025-03-31 | $2.0M | −$6.1M | −75.74% |
| Q4 2024 | 2024-12-31 | $3.2M | −$7.8M | −70.77% |
| Q3 2024 | 2024-09-30 | $3.8M | −$1.5M | −28.23% |
| Q2 2024 | 2024-06-30 | $15.3M | $10.7M | +230.74% |
| Q1 2024 | 2024-03-31 | $8.1M | $2.7M | +50.91% |
| Q4 2023 | 2023-12-31 | $11.0M | $5.1M | +85.68% |
| Q3 2023 | 2023-09-30 | $5.3M | $871,197 | +19.88% |
| Q2 2023 | 2023-06-30 | $4.6M | $953,049 | +25.91% |
| Q1 2023 | 2023-03-31 | $5.4M | $1.7M | +46.39% |
| Q4 2022 | 2022-12-31 | $5.9M | $2.8M | +90.70% |
| Q3 2022 | 2022-09-30 | $4.4M | $289,296 | +7.07% |
| Q2 2022 | 2022-06-30 | $3.7M | $926,884 | +33.69% |
| Q1 2022 | 2022-03-31 | $3.7M | $258,107 | +7.56% |
| Q4 2021 | 2021-12-31 | $3.1M | — | — |
| Q3 2021 | 2021-09-30 | $4.1M | $1.4M | +51.08% |
| Q2 2021 | 2021-06-30 | $2.8M | −$29,014 | −1.04% |
| Q1 2021 | 2021-03-31 | $3.4M | — | — |
| Q3 2020 | 2020-09-30 | $2.7M | — | — |
| Q2 2020 | 2020-06-30 | $2.8M | — | — |
HCW Biologics operating expenses trends
Over the last five fiscal years, HCW Biologics's operating expenses increased from $9.9M to $13.2M, a change of $3.2M. The latest reported quarter, Q2 2026, shows $3.1M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCW Biologics source filings ↗